8-144515430-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004260.4(RECQL4):c.1286G>A(p.Gly429Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.1286G>A | p.Gly429Glu | missense_variant | Exon 7 of 21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.215G>A | p.Gly72Glu | missense_variant | Exon 6 of 20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000532846.2 | c.170G>A | p.Gly57Glu | missense_variant | Exon 3 of 9 | 5 | ENSP00000476551.1 | |||
RECQL4 | ENST00000688394.1 | n.309G>A | non_coding_transcript_exon_variant | Exon 1 of 4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152198Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00000810 AC: 2AN: 247038Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134480
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460474Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 726504
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152198Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74348
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1286G>A (p.G429E) alteration is located in exon 7 (coding exon 7) of the RECQL4 gene. This alteration results from a G to A substitution at nucleotide position 1286, causing the glycine (G) at amino acid position 429 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 429 of the RECQL4 protein (p.Gly429Glu). This variant is present in population databases (rs761033231, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 406964). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at